Reports: National Oncology Institute (Slovakia): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 9: Line 9:


'''Data level:''' [[dataLevel::national level]] and [[dataLevel::regional level]].
'''Data level:''' [[dataLevel::national level]] and [[dataLevel::regional level]].
'''Cancer areas of interest:''' [[hasCancerType::C00-D48: All neoplasms]]. [https://www.noisk.sk/o-nas/vyrocne-spravy Click here to learn more].


'''Access to information:''' For annual reports [https://www.noisk.sk/o-nas/vyrocne-spravy click here to access]. For screenings information [https://www.noisk.sk/files/2023/2023-07-04-noi-rocenka-skriningy-2022-sk.pdf click here to access]; For epidemiological report of cancer diseases [https://www.noisk.sk/files/2023/2023-02-03-epidemiologicka-sprava-svetovy-den-proti-rakoviny-4-februar.pdf click here to access].
'''Access to information:''' For annual reports [https://www.noisk.sk/o-nas/vyrocne-spravy click here to access]. For screenings information [https://www.noisk.sk/files/2023/2023-07-04-noi-rocenka-skriningy-2022-sk.pdf click here to access]; For epidemiological report of cancer diseases [https://www.noisk.sk/files/2023/2023-02-03-epidemiologicka-sprava-svetovy-den-proti-rakoviny-4-februar.pdf click here to access].

Revision as of 18:32, 23 May 2024

Go back to Slovakia page

Primary purpose: To function as a clinical-research, academic, and educational platform to support the National Oncology Program in various areas, including epidemiology, science, research, prevention, screening, diagnosis, treatment, and supportive care.

Sponsor, manager or home institution: Národný Onkologický Inštitútu.

Type of information: The most common cancers; Cancer diseases; Overview of the availability of palliative care in the health system; Number of capacities in palliative care; Availability of original oncology treatment; Cost-effectiveness of colorectal cancer screening; Participation in opportunistic colorectal cancer screening; Number of breast, cervical, colorectal and lung screenings; Rate of participation in screenings; estimated rate of coverage; Share of clinical stages of malignant tumors; Number and percentage of clinical stages of malignant tumors; List of verified screening mammography workplaces; Number of women invited to a screening mammography examination; Relative rate of women's participation in mammography screening; Number of diagnosed malignancies during mammography screening.

Data level: national level and regional level.

Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.

Access to information: For annual reports click here to access. For screenings information click here to access; For epidemiological report of cancer diseases click here to access.